Leigh Revers, MA, DPhil, is currently Senior Lecturer in biotechnology and Associate Director of the Master of Biotechnology (MBiotech) Program at the University of Toronto in Ontario, Canada. He is also cross-appointed to the Institute of Management & Innovation. He came to the university with an extensive background in biotechnology entrepreneurship, and he has more than 20 years of experience working in the life sciences sector, both in academia and industry. Trained as a chemist and molecular biologist in the Dyson Perrins Laboratory in Oxford, United Kingdom, he first came to Canada in 1996 as the recipient of a Leverhulme Scholarship to work with Professor Harry Schachter on developmental enzymes involved in human diseases at Toronto’s Hospital for Sick Children. Since then, he has worked at a number of Canada’s other premier research institutes, including the Ontario Cancer Institute at Princess Margaret Hospital and the Samuel Lunenfeld Research Institute at Mount Sinai Hospital.